-
Piper Sandler Downgrades Kronos Bio Inc. (KRON) to Neutral
-
TD Cowen Downgrades Kronos Bio Inc. (KRON) to Hold
-
Piper Sandler Reiterates Overweight Rating on Kronos Bio Inc. (KRON)
-
Kronos Bio Inc. (KRON) Announces Selection of Autoimmune Development Candidate for Sjogren's Disease
-
Kronos Bio, Inc. (KRON) Tops Q2 EPS by 9c

